Navigation Links
CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million
Date:5/14/2008

BRANFORD, Conn., May 14 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) announced today the completion of a series of privately negotiated transactions with holders of the Company's 4% Convertible Subordinated Notes due February 2011 (the "2011 Notes") in which the Company retired a total of $50.9 million of the 2011 Notes for an aggregate purchase price of $43.2 million, reflecting an aggregate discount of approximately 15.1% off of face value. CuraGen currently has approximately $100 million or $1.72 per share, in cash and investments on hand, and has $19.0 million of the 2011 Notes outstanding.

With the completion of these transactions, CuraGen will eliminate a total of approximately $5.6 million in interest payments on the 2011 Notes to maturity. The Company now anticipates ending 2008 with cash and investments of approximately $92 million, or $1.59 per share.

"Our planned, systematic strengthening of CuraGen's balance sheet continues with these latest transactions, which have increased our net cash position by approximately $8 million," stated Dr. Timothy Shannon, President and Chief Executive Officer of CuraGen Corporation. "Over the past 16 months, we have increased our net cash position by approximately $87 million, while eliminating over $157 million in debt and over $40 million in annual operating and interest expenses. We believe we are well capitalized with over $100 million to develop our un-partnered antibody drug conjugate, CR011-vcMMAE, in metastatic melanoma and breast cancer and to explore other potential near-term value creation opportunities."

About CuraGen

CuraGen Corporation (Nasdaq: '/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer
2. CuraGen Appoints Clinical Oncologist as VP of Medical Development
3. CuraGen to Present at the 19th Annual Piper Jaffray Health Care Conference
4. CuraGen and TopoTarget Announce Initiation of an NCI-sponsored Phase II Clinical Trial of Belinostat for Thymoma and Thymic Carcinoma
5. CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
6. CuraGen Corporation Receives Notification from NASDAQ
7. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
8. CuraGen to Present at the BIO CEO & Investor Conference
9. CuraGen Sells Ownership of Belinostat to TopoTarget A/S
10. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
11. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...the Practical Implementation of ... October 13 /- After the successful,s...ram at the beginning of,the year, Ziehm Imaging, p...consequently expanding its training offer. The Zie...ional standards, in order to keep its,partners up ...
(Date:10/13/2008)... 13 /-,Following fulfillmen...,completed the acquisition* of all outstanding sha...escription optical equipment., Satisloh designs a...ing,machines, as well as consumables, for prescrip...evenue in 2007 and employs more than 400 people,ar...
(Date:10/11/2008)...ire/ -- MedImmune announced today it,will present ...cs (AAP),2008 National Conference & Exhibition tha...to the prevention of respiratory syncytial virus (...on among preterm infants., "As we gain data that ...reterm babies, the benefits of preventive care bec...
(Date:10/10/2008)...swire-FirstCall/ -- Neurobiological,Technologies, ... will hold a,conference call on Monday, October 13...) Phase 3 Trial Program for acute ischemic stroke....nt and chief executive,officer and Warren W. Wasie...October 13, 2008 -- Time: 1:00 p.m. (ET), 12:00 ...
Breaking Biology Technology:Ziehm Imaging Extends its Training Offer 2Ziehm Imaging Extends its Training Offer 3Ziehm Imaging Extends its Training Offer 4MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 2MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 3MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 4MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 5Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2
...ill assume duties as director of the state Depart...merce Secretary Cory Nettles announced the hire ...initiative. , ,Part of the key to our successful ...ty really lie in collaborative efforts. We hope to...sted in starting technology businesses to the righ...
...e it, not all technologists are the life of the pa...r respective fields and even visionary in how they... and networking isnt often their strength. In fact...How do you know when two techies are talking? They...was no time for shoe-staring at Connections: Chip...
...Gov. Jim Doyle took office last year he faced the ... a gap of nearly 3.2 billion dollars and a challe...vernor. , ,However, at the 2004 Governors Confere...ssed a crowd of industry and civic representatives...industry has helped raise the state beyond its tro...
... is a nation deeply imbued with Confucian values, ... from ancestors and should never be tampered with....l last week when South Korean researchers announce...an embryo and then collect from it master stem ce...w their own replacement tissues. , ,For every Sout...
Other Biology Technology:Nettles Names Christenson as Director of Bureau of Entrepreneurship 2Pushing the Fast-Forward Button on Networking Does It Work? 2Doyle Preaches Importance of Tech Industry at Summit 2How Wisconsin Can Maintain Its Lead in Stem Cell Research 2How Wisconsin Can Maintain Its Lead in Stem Cell Research 3
(Date:10/12/2008)...ogy journal (October 12th) reveals how scientists...t UCL are using a novel nanomechanical approach to...e few antibiotics that can be used to combat incre...earchers, led by Dr Rachel McKendry and Professor ...apable of providing new insight into how antibioti...
(Date:10/10/2008)... world,s top scientists and clinicians in the huma...resent their latest research findings at the 58th ...enetics (ASHG) from Tuesday, November 11, through ...Convention Center., Founded in 1948, ASHG is the ...uman genetics,specialists worldwide, representing...
(Date:10/10/2008)...Governor Jim Doyle today announced a historic coll...ions to advance personalized health care leading t... The Wisconsin Genomics Initiative is a collaborat...edical College of Wisconsin (MCW), University of W...MPH) and UW-Milwaukee (UWM). , Wisconsin is a le...
(Date:10/10/2008)...l, will be the focus of the Society for Nutrition ...e event is just one small step in fighting world h... the world and requires immediate attention in ord..., hunger and deficiencies. The Society for Nutriti...public to get involved and make a difference in th...
Breaking Biology News(10 mins):Nanotechnology boosts war on superbugs 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 3The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 4The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 5Governor Doyle announces historic genomic research collaboration 2World Food Day brings attention to food security around the globe 2Rigel to Present at BIO CEO 26 Investor Conference 3058 1Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 1Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 2Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 3Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results 3057 1Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results 3057 2Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 1Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 2Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 3
...y comparing 140 sequenced bacterial genomes, resea...s essential to bacterial replication ?and they did.... , Mikhail Gelfand, a Howard Hughes Medical Inst...ute for Information Transmission Problems (IITP) i...onov, used comparative genomics to identify a new ...
... first-of-its-kind multi-center trial has shown th...hildren who suffered traumatic brain injury. , The... Pittsburgh neurosurgeon P. David Adelson, MD, and...te hypothermia initiated after severe traumatic br...n for children. , TBI initiates several metabolic...
...he 2004-2005 flu season was at least as severe as ...o data from Solucient, a leading provider of healt...ted the most recent flu season from being even wor...ital admissions for community-acquired pneumonia (...flu. Solucient analyzed CAP discharge data from Oc...
...esearch into a new treatment for nerve damage caus...iabetic patients, say experts. , The treatment mi...and feet if early effects on nerve protection and ...e in diabetes is the major cause of non-traumatic .... , Scientists at The University of Manchester, wo...
Other Biology News:Bioinformatics reveals new gene regulation system 2Bioinformatics reveals new gene regulation system 3Study Finds Moderate Hypothermia A Safe Treatment For Traumatic Brain Injury In Kids 2Diabetic nerve therapy shows 'striking' results 2
...madzu Biotech presents PsiPort Mass Directed Auto ... data acquisition system designed for automated co...ence and pharmaceutical discovery programs. The sy...gh throughput mass directed auto purification for ...
The Rapid DNA Ligation Kit enables ligation of sticky-end or blunt-end DNA fragments in just 5 min at 15-25 C. Depending on the DNA concentration, either circular (low DNA concentration) or concatem
Nuclease S7; Micrococcal nuclease from Roche Applied Science
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature.
Biology Products: